Cabazitaxel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1396 publications
A Review on Analytical Insights into Impurity Profiling of Selected Anticancer Agents: Tinibs and Taxanes.
Journal: Critical reviews in analytical chemistry
Published: August 23, 2026
Taxane therapy in mCRPC: current positioning and emerging strategies to overcome resistance.
Journal: Expert opinion on investigational drugs
Published: August 19, 2026
Clinical and economic outcomes of cabazitaxel versus Lu-PSMA in mCRPC: a US perspective.
Journal: Journal of medical economics
Published: August 07, 2026
Self-assembled nanocomplexes of polyphenol-modified prodrugs and transferrin enable cascade-targeted and redox-activated chemotherapy.
Journal: Materials horizons
Published: July 28, 2026
Reply to "Cost-Effectiveness of 177Lu-PSMA-617 Versus Cabazitaxel: Accounting for Real-World and Health Equity Considerations".
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 27, 2026
A Phase 2 Trial of Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) for the Treatment of Non-Muscle Invasive BCG Unresponsive Urothelial Carcinoma of the Bladder.
Journal: The Journal of urology
Published: July 17, 2026
Prostate Cancer: Etiology, Diagnosis, and Treatment.
Journal: Serican journal of medicine
Published: June 30, 2026
Transient PSA Suppression Without Survival Benefit: Real-World Comparative Effectiveness of Cabazitaxel Plus Carboplatin in Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Journal: Clinical genitourinary cancer
Published: June 11, 2026
Biomimetic PD-1-MSCs membrane-engineered nanoparticles for enhanced blood-brain barrier penetration and anti- glioma therapy.
Journal: Frontiers in immunology
Published: June 11, 2026
Real-World Outcomes of DNA Damage Repair Altered Metastatic Castration-Resistant Prostate Cancer: Insights from FFPE-Based Genomic Profiling.
Journal: Cancers
Published: June 10, 2026
Time-Dependent Effects of PFAS and Their Mixtures on Ovarian Epithelial Cell Proliferation and Chemotherapeutic Response.
Journal: International journal of molecular sciences
Published: May 19, 2026
Interstitial lung abnormalities progression upon treatment with cabazitaxel for metastatic prostate cancer.
Journal: Polish archives of internal medicine
Published: May 08, 2026
Last Updated: 09/26/2026